ERN EURO-NMD

Neuromuscular diseases (NMDs) occur from early childhood to late adulthood and are characterised by muscle weakness and wasting, but may be associated with other symptoms, including fatigue, pain, numbness, blindness, swallowing difficulties, breathing difficulties and heart disease. Most NMDs are progressive and debilitating, with reduced lifespan and quality
of life.

There are significant gaps and disparities in access to diagnostics and treatment across Europe. Major challenges in improving outcomes include the delay in referral from primary care to a specialist centre, and managing the transition from paediatric to adult services.

ERN EURO-NMD unites Europe’s leading experts to provide patients with access to specialist care through virtual and in-person consultations. The network aims to reduce time to diagnosis by 40% in its first 5 years, to improve diagnostic yield by 15% and to increase access to appropriate care pathways.

In addition, ERN EURO-NMD will develop new guidelines and provide healthcare professionals and patients with disease-specific best-practice information. The knowledge generated and curated by the network will be widely available through eHealth tools. Building on a strong legacy of cooperation, the network will also foster collaborations with the potential to drive research and therapy development to address unmet patient needs.

Registry

Contact information

Publications

pubmed-logo

Below an overview is given of scientific publications related to ERN EURO-NMD. Publications were obtained from the PubMed database. All publications where one of the authors has an affiliation link where “ERN EURO-NMD” is mentioned, are added to the publication overview automatically. Updates are performed once a week.

Filter list publications

TitleAuthorsDateKeywordsIssue name
Correction: Scleromyxedema-Associated Myopathy and Vacuolar Myopathy with Monoclonal Gammopathy and Stiffness (VAMMGAS) as manifestations of Monoclonal Gammopathy of Clinical Significance (MGCS): a disease spectrum between autophagy dysfunction and inflammation.Nicoletti T, Benveniste O, Battistella M, Mahevas T, Arnulf B, Stojkovic T, Staedler K, Maisonobe T, Letournel F, Romero P, Malfatti E, Vignon M, Nadaj-Pakleza A, Labella B, Lacene E, Brochier G, Evangelista T, Leonard-Louis S2026-11-03Journal of neurology
Genetic insights into multiple sclerosis: exploring mitochondrial DNA and nuclear POLG gene variation in a Polish single-center RRMS cohort.Piotrowska-Nowak A, Kierdaszuk B, Dziedzicka AM, Kaliszewska M, Podlecka-Piętowska A, Tońska K2026-10-05EDSS, POLG gene, genetic variation, mitochondrial DNA, mitochondrial disorders, multiple sclerosis, relapsesNeurologia i neurochirurgia polska
Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks.Dollfus H, Arzimanoglou A, Evangelista T, Graessner H, Mosca M, Sangiorgi L, Blay JY, Bodemer C, Fenaux P, Hernández F, Jondeau G, Ligtenberg MJL, Lohse AW, Mathijssen IMJ, Mulders P, Pereira AM, Schaefer F, Swart JF, Verloes A, Wagner TOF, Wijnen RMH, Wilde AAM, Pereira MDMM, Ladenstein R, Scarpa M2026-10-01Climate change, Continuity of care, Crisis preparedness, Cross-border healthcare, European Reference Networks, Health emergency response, Health system resilience, Healthcare pathways, Pandemics, Rare diseasesThe Lancet regional health. Europe
Scleromyxedema-Associated Myopathy and Vacuolar Myopathy with Monoclonal Gammopathy and Stiffness (VAMMGAS) as manifestations of Monoclonal Gammopathy of Clinical Significance (MGCS): a disease spectrum between autophagy dysfunction and inflammation.Nicoletti T, Benveniste O, Battistella M, Mahevas T, Arnulf B, Stojkovic T, Staedler K, Maisonobe T, Letournel F, Romero P, Malfatti E, Vignon M, Nadaj-Pakleza A, Labella B, Lacene E, Brochier G, Evangelista T, Leonard-Louis S2026-09-29Autophagy, MGUS, Monoclonal gammopathy, Scleromyxedema, VAMMGAS, Vacuolar myopathyJournal of neurology
Muscle biopsy to end a diagnostic odyssey in a genetically complex case of spinal muscular atrophy type 3: the importance of "old school" in the next-generation sequencing era.Mensdorff-Pouilly A, Schmidt I, Wiesenhofer A, Rappold M, Bittner RE, Bernert G, Schmidt WM2026-09-29European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Diagnostic and therapeutic challenges in Andersen-Tawil syndrome.Jacobsen SB, van der Werf C, van der Kooi AJ, Wilde AAM, Tfelt-Hansen J2026-09-17Andersen-Tawil syndrome, Dysmorphologies, Periodic paralysis, KCNJ2, Kir2.1, U wave, Bidirectional ventricular tachycardia, Ventricular arrhythmiasHeart rhythm
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.Gervais A, Marchal A, Maillard A, Le Voyer T, Rosain J, Philippot Q, Bizien L, Peel J, Cederholm A, Migaud M, Pons S, Saker K, Laforet P, Aubart M, Gitiaux C, Biggs CM, Lopez RL, Souvannanorath S, Tard C, Pakleza AN, Grapperon AM, Heming N, Annane D, Verschueren A, Attarian S, Bigaut K, Hankiewicz K, Kouton L, Villar-Quiles RN, Cauquil C, Fleury MC, Rocher E, Nicolas G, de Paula Estephan E, da Penha Ananias Morita M, Zanoteli E, Saied Z, Rachdi A, Rim A, Belal S, Ben Sassi S, Hübers A, Faure E, Desguerre I, Basse C, Girard N, Béziat V, Pan-Hammarström Q, Hammarström L, Bodansky A, Parent AV, Anderson MS, DeRisi JL, Demeret S, Truffault F, Fort R, Ader F, Wallet F, Trouillet-Assant S, Abel L, Molina T, Alyanakian MA, Le Panse R, Solé G, Cobat A, Landegren N, Casanova JL, Puel A, Bastard P, Jouanguy E2026-08-04COVID-19, autoantibodies, interferons, myasthenia gravisProceedings of the National Academy of Sciences of the United States of America
Comprehensive Care Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method.Narayanaswami P, Mantegazza R, Barnett-Tapia C, Cortés-Vicente E, Freimer ML, Gilhus NE, Habib AA, Howard JF, Kostera-Pruszczyk A, Leite MI, Meisel A, Pasnoor M, Sacconi S, Silvestri NJ, Stevens J, Suzuki S, Uzawa A, Wolfe GI, Utsugisawa K2026-08-01Neurology. Clinical practice
Bis(monoacylglycero)phosphate (BMP) as a circulating biomarker of lysosomal dysfunction in GNE myopathy.Manis C, Pertusati F, Morewood J, Roos A, Kleefeld F, Onali M, Pogoryelova O, Derksen A, Spendiff S, Lochmuller H, Videira P, Atzori L, Caboni P2026-07-25BMP, GNEM, Nonaka myopathy, HIBM, Lipidomics, Lysosomal alterationClinica chimica acta; international journal of clinical chemistry
Neuromuscular Symptoms of ORAI1-Related Immunodeficiency.Jędrzejowska M, Potulska-Chromik A, Czeczko K, Franaszczyk M, Wolska-Kuśnierz B, Rosiak E, Aragon-Gawińska K, Stokłosa T, Kostera-Pruszczyk A2026-07-02genetics, myopathy, other, pediatricJournal of child neurology
Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.Conrad S, Toquet C, Fradin M, Wahbi K, Ghorab K, Leborgne AS, Benbrik N, Péréon Y, Magot A, Perrier-Boeswillwald J, Pattier S, Trochu JN, Probst V, Dorent R, Nadaj-Pakleza A, Amthor H, Quijano-Roy S, Cossée M, Tuffery-Giraud S, Duboc D, Leturcq F, Stojkovic T, Yaou RB, Mercier S2026-06-23Dilated cardiomyopathy, Duchenne muscular dystrophy, Dystrophinopathy, Female carriers, Heart failure, Heart transplantation, X-chromosome inactivationNeuromuscular disorders : NMD
Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.Cintas P, Salort-Campana E, Demeret S, Stanbury T, Bouquillon B, Nadaj-Pakleza A, Gallard J, Solé G, Attarian S2026-06-03Generalised myasthenia gravis, Healthcare management, Myasthenia gravis, Neurologist's perspective, Ocular myasthenia gravisRevue neurologique
Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].Donofrio PD, Gorson KC, Hofman E, Karam C, Kira JI, Kostera-Pruszczyk A, Léger JM, Nobile-Orazio E, Attarian S, Markov M, Tse A, De Roeck A, Lewis RA2026-05-13Journal of the neurological sciences
Diet and nutrition in patients with neuromuscular disorders, as lifestyle factors affecting clinical parameters and quality of life: a narrative systematic review.Marconi S, Gilberti G, Zanini B, Marullo M, Montani G, Risi B, Padovani A, Castellano M, Filosto M2026-04-24diet, emotional perception and care, lifestyle, neuromuscular disorders, physical activity, quality of lifeNutrition research reviews
Long-term clinical and radiological trajectories in ANO5-related myopathies highlight muscle MRI as a predictor of disease progression.Aragon-Gawinska K, Martí P, Azorín I, Sivera R, Aller E, Pitarch I, Benlloch C, Tárrega M, Vilar R, Díaz C, Sánchez-Roy R, Más-Estellés F, Frasquet M, Vázquez-Costa JF, Otero-Borell M, Vilchez R, Vilchez JJ, Sevilla T, Muelas N2026-04-15ANO5, Anoctamin, Distal myopathies, Limb-girdle muscular dystrophies, Magnetic resonance imagingJournal of neurology
European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.Graessner H, Ripp S, Pereira AM, Schaefer F, Mathijssen I, Blay JY, Mulders PFA, Evangelista T, Ligtenberg MJL, Wilde AAM, Ladenstein R, Lohse AW, Mosca M, Swart JF, Hernández F, Fenaux P, Dollfus H, Verloes A, Wagner T, Bodemer C, Wijnen R, Scarpa M, Jondeau G, Tumienė B, Gallina S, Arzimanoglou A, Sangiorgi L2026-04-14Clinical patient management system, Cross-border healthcare, EU4Health, European Reference Networks, European health union, JARDIN, Patient-centred care, Rare diseasesOrphanet journal of rare diseases
Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.Donofrio PD, Gorson KC, Hofman E, Karam C, Kira JI, Kostera-Pruszczyk A, Léger JM, Nobile-Orazio E, Attarian S, Markov M, Tse A, De Roeck A, Lewis RA2026-04-12Chronic inflammatory demyelinating polyradiculoneuropathy, Clinical trial, Diagnostic adjudication committee, Diagnostic guidelines, Efgartigimod, Patient adjudicationJournal of the neurological sciences
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.Gervais A, Marchal A, Maillard A, Le Voyer T, Rosain J, Philipot Q, Bizien L, Peel J, Cederholm A, Migaud M, Pons S, Saker K, Laforet P, Aubart M, Gitiaux C, Biggs C, Leon Lopez R, Souvannanorath S, Tard C, Nadaj Pakleza A, Grapperon AM, Heming N, Annane D, Verschueren A, Attarian S, Bigaut K, Hankiewicz K, Kouton L, Villar-Quiles RN, Cauquil C, Fleury MC, Rocher E, Nicolas G, de Paula Estephan E, da Penha Ananias Morita M, Zanoteli E, Saied Z, Rachdi A, Rim A, Belal S, Ben Sassi S, Hübers A, Faure E, Desguerre I, Basse C, Girard N, Béziat V, Pan-Hammarström Q, Hammarström L, Bodansky A, Parent AV, Anderson MS, DeRisi JL, Demeret S, Truffault F, Fort R, Ader F, Wallet F, Abel L, Molina T, Alyanakian MA, Le Panse R, Solé G, Cobat A, Landegren N, Casanova JL, Puel A, Bastard P, Jouanguy E2026-04-02Biological Sciences, COVID-19, Immunology and Inflammation, autoantibodies, interferons, myasthenia gravismedRxiv : the preprint server for health sciences
Laminopathies: natural history and risk prediction of heart failure.Charron P, Proukhnitzky J, Ben Yaou R, Richard P, Dembélé M, Urtis M, Gossios T, Kumar S, Savvatis K, Stojkovic T, Anselme F, Maury P, Gandjbakhch E, Martins R, Sacher F, Trochu JN, Rouanet S, Lejeune J, Moubarak G, Fayssoil A, Marijon E, Laforêt P, Béhin A, Leonard-Louis S, Sole G, Labombarda F, Metay C, Quijano-Roy S, Dabaj I, Klug D, Habib G, Vantyghem MC, Chevalier P, Salort-Campana E, Sellal JM, Waintraub X, Zeppenfeld K, Amin AS, Kramarenko DR, Pinto YM, Landstrom A, Serio A, Chikhaoui C, Combes N, Barnerias C, Bécane HM, Bieth E, Boccara F, Bonnet D, Bouhour F, Brehin AC, Cintas P, Roubille F, Lamblin N, de Groote P, Winum PF, Piriou N, Réant P, De Sandre-Giovannoli A, Masingue M, Desguerre I, Durigneux J, Echaniz-Laguna A, Eschalier R, Ferreiro A, Fradin M, Gaborit B, Gay A, Hagège A, Isapof A, Jeru I, Lagrue E, Laugel V, Lazarus A, Leturcq F, Magot A, Manel V, Mercier S, Meune C, Michaud M, Minot-Myhié MC, Nadaj-Pakleza A, Péréon Y, Petit F, Praline J, Rollin A, Sarret C, Taithe F, Tard C, Tiffreau V, Fauchier L, Vatier C, Walther-Louvier U, Schurr B, Bobin P, El Hachmi M, Billon C, Fontaine B, Vigouroux C, Lakdawala NK, Arbustini E, Elliott P, Bonne G, Wahbi K2026-03-06LMNA, Dilated cardiomyopathy, Heart failure, Lamin gene, PredictionEuropean heart journal
French National Protocol for Diagnosis and Care of Calpainopathy (LGMD R1/LGMD D4): consensus guidelines for clinical practice.Severa G, Souvannanorath S, Tahiri I, Alimi C, Slioui A, Villa L, Salort-Campana E, Leturcq F, Streichenberger N, Krahn M, Solé G, Feasson L, Nadaj-Pakleza A, Tard C, Stojkovic T, Sacconi S, Malfatti E2026-02-27CAPN3, Calpainopathy, guidelines, managementOrphanet journal of rare diseases
A roadmap for a patient-centred approach to Pompe disease management.Schoser B, Domínguez-González C, Laforet P, Hahn A, Gissen P, Kostera-Pruszczyk A, Thalmeier A, Vissing J2026-02-14Centres of excellence, Gene therapy, Multidisciplinary team, Pompe disease, Rare genetic disorder, Think-tank methodologyJournal of neurology
Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.Lopriore P, Ünlütürk Z, Klopstock T, Karaa A, Rouzier C, Domínguez-González C, Lamperti C, Mancuso M, Cecchi G, Montano V, Siciliano G, Nicoletta V, Maioli M, Primiano G, Servidei S, La Morgia C, Carelli V, Valentino ML, Caporali L, Arena IG, Musumeci O, Lopergolo D, Malandrini A, Gallus GN, Filosto M, Bello L, Pegoraro E, Comi GP, Magri F, Ronchi D, Di Fonzo A, Percetti M, Azzimonti M, Büchner B, Prokisch H, Bermejo-Guerrero L, Procaccio V, Gaignard P, Echaniz-Laguna A, Schiff M, Rötig A, Toutain A, Paquis-Flucklinger V, Morel G, Robin S, Nadaj-Pakleza A, Chanson JB, Chaussenot A, Ait-El-Mkadem Saadi S, Trimouille A, Tranchant C, Salort-Campana E, Bieth E, Sacconi S, Duval F, Restrepo Vera JL, Molnar MJ, Vissing J, Haas R, Larson A, Enns GM, Parikh S, Goldstein A, Hirano M2026-02-10Neurology
A real-world, multicentre, epidemiological study in Czech and Slovak adults with spinal muscular atrophy treated with risdiplam.Parmova O, Prasil K, Mokra L, Svoboda M, Ridzon P, Junkerova J, Bakosova L, Okalova K, Jurikova L, Kolnikova M, Haberlova J2026-02-06Adults, Real-world data, Risdiplam, Spinal muscular atrophyScientific reports
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia.Kyriakides T, Aleksovska K, Angelini C, Argov Z, Claeys KG, de Visser M, FIlosto M, Jovanovic I, Kostera-Pruszczyk A, Molnar MJ, Sacconi S, Schaefer J, Siciliano G, Vilchez JJ, Schoser B, Toscano A2026-02-01GRADE, creatine kinase, diagnostic techniques and procedures, guidelines, muscle biopsy, oligo/asymptomatic hyperCKemiaEuropean journal of neurology
Apoptosis and motor deficits in SPG76 hereditary spastic paraplegia: Calpain 2 inhibition as therapeutic strategy.Brivio F, Guarato G, Panzeri E, Manganelli F, Filosto M, Vantaggiato C, Bassi MT2026-01-29Apoptosis, Calpain 1, Calpain 2, MDL28170, Olesoxime, SPG76Pharmacological research
Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors and tafamidis treatment outcomes.Gawor-Prokopczyk M, Grzybowski J, Lipowska M, Truszkowska G, Ponińska J, Rajtar-Salwa R, Susuł M, Keller D, Straburzyńska-Migaj E, Dąbrowska-Kugacka A, Mazurkiewicz Ł2026-01-07ATTR, cardiac amyloidosis, tafamidis, transthyretin amyloidosisKardiologia polska
Muscle MRI Contributes to the Differential Diagnosis Between Distal Myopathies and Distal Hereditary Motor Neuropathies.Payá M, Portela S, Sivera R, Frasquet M, Más-Estellés F, Martí P, Azorín I, Aragon-Gawinska K, Tárrega M, Argente-Escrig H, Vázquez-Costa JF, Vilchez R, Vilchez JJ, Sevilla T, Muelas N2026-01-01distal hereditary motor neuropathies, distal myopathies, muscle MRI, muscle islands, neuromyopathiesEuropean journal of neurology
Diagnostic Yield and Genotype-Phenotype Correlations of Clinical Exome Sequencing in Hereditary Spastic Paraparesis: Experience From Eastern Spain.Carretero-Vilarroig L, Sivera R, Baviera R, Espinós C, Muelas N, Vazquez-Costa JF, Aller E, Bataller L, Jaijo T2026-01-01exome sequencing, muscle spasticity, spastic paraparesisEuropean journal of neurology
Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.Ibañez-Lligoña M, Colomer-Castell S, Campos C, González-Camuesco Á, Llauradó A, Garcia-Larroy J, Sánchez-Tejerina D, Rando-Segura A, Andrés C, Esperalba J, Nadal P, Ferrer R, Cortese MF, Tabernero D, Gregori J, Riveiro-Barciela M, Ruiz-Cobo JC, Ruiz A, Del Barco E, Buti M, Goya M, Antón A, Cano A, Juntas-Morales R, Quer J2026-01-01coinfection, diagnostics, metagenomics, sequencing, virologyFrontiers in microbiology
European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research framework.Fortunato F, Selvatici R, Kirschner J, Sansen S, Agolini E, Ottombrino S, Bertini E, Novelli A, Einhorn M, Matalonga L, Beltran S, Gut IG, Pereira AM, Hiort O, Schaefer F, Verloes A, Lohse AW, Wilde AAM, Bodemer C, Jondeau G, Dollfus H, Graessner H, Mathijssen IMJ, L'khssim I, Blay JY, Sangiorgi L, Fenaux P, Mañú Pereira MDM, Gutiérrez Valle V, Mosca M, Hoogerbrugge N, Wijnen R, Evangelista T, D'Angelo C, Wagner TOF, Feitz WFJ, Ladenstein R, Dobai Z, Wulffraat N, Ruperto N, Jara Vega P, Bellettato CM, Scarpa M, Onali M, Tchaicha S, Arzimanoglou A, Oh J, Lenz D, Tumiene B, Zygmunt A, Ferlini A2026-01-01European reference networks (ERNs), genomic newborn screening, healthcare pathways, operational workflow, rare genetic diseases, screen4care, treatable genetic disordersFrontiers in public health
Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophy.Coratti G, Bravetti C, Cicala G, Cutrì C, Sansone VA, D'Amico A, Bruno C, Messina S, Ricci F, Mongini T, Coccia M, Pegoraro E, Masson R, Berardinelli A, Agosto C, Pini A, Varone A, Turri M, Filosto M, Comi G, Maggi L, Bruno I, D'Angelo MG, Trabacca A, Vacchiano V, Sacchini M, Gagliardi D, D'Errico E, Ruggiero L, Verriello L, Brighina F, Garibaldi M, Zuccarino R, Nigro V, Battini R, Ricci G, Siliquini S, Zambon AA, Polikar B, Pera MC, Pane M, Mercuri E2026-01-01disease registry, longitudinal data, neuromuscular disorders, real-world data, spinal muscular atrophyFrontiers in neurology
Spinal muscular atrophy with five SMN2 copies: Phenotypic heterogeneity and implications for newborn screening and treatment decisions.Parmova O, Adamova B2026-01-01SMN2 copy number, genotype–phenotype correlation, newborn screening, phenotypic heterogeneity, presymptomatic SMA, spinal muscular atrophyFrontiers in neurology
Clinical, Histological, and Genetic Characterization of a Large Cohort of 49 Patients With Nebulin-Related Congenital Myopathy.de Feraudy Y, Maino A, Boedec M, Lornage X, Romero NB, Monges S, Lubieniecki F, Foncuberta ME, Tard C, Maurage CA, Csanyi M, Marcorelles P, Stojkovic T, Feasson L, Fradin M, Gousse G, Laugel V, Masingue M, Nadaj-Pakleza A, Bevilacqua JA, Neb Study Group, Rendu J, Bohm J, Biancalana V, Laporte J2026-01-01Human mutation
Early Dropped Head Syndrome Is More Prevalent in C9orf72 and FUS/TLS ALS.Gamez J, Carmona F, Syriani EE, Morales-Fuciños M, Gamez A2025-12-26C9orf72, FUS/TLS, SOD1, ALS genetics, amyotrophic lateral sclerosis, epidemiology, survivalMuscle & nerve
Addressing unmet needs in pregnancy and family planning of people living with rare and low-prevalence diseases: results of the "ERN transversal working group on pregnancy and family planning" survey.Fulvio G, Marinello D, Zucchi D, Aguilera S, Benachi A, Biller R, Blanco I, Boiteux MC, Borgards P, Brandi ML, Costafreda E, Fonseca JE, Fredi M, Guimarães V, Iotova V, Lecointe-Artzner E, Lopes AR, Louisse S, Nalli C, Olesinska M, Onali M, Papenthin W, Power B, Röhl C, Rousset-Jablonski C, Sturz D, Tincani A, van Vleuten CJ, Vieira A, Dan D, Backer J, Smulders CD, Dufke A, Frank C, Limongelli G, Lorenz B, Kilpiäinen E, Pascau MJ, Raidt J, Ray-Coquard I, Rimmer R, Schneider H, Van Pal HJ, Yap T, Talarico R, Tani C, Mosca M2025-11-25Patient-centered care european reference networks (ERN), Pregnancy, Psychological support, Rare diseases, Reproductive health, Unmet needsReproductive health
Phenotypic spectrum of variants in the FIG4 gene: variants associated with Charcot-Marie-Tooth 4J and parkinsonism.Lauerova B, Mazanec R, Eggerman K, Safka Brozkova D, Lischka A, Seeman P, Mikula M, Lassuthova P2025-10-31Charcot-Marie-Tooth type 4J, FIG 4, Hereditary peripheral neuropathy, Parkinsonism, Structural brain abnormalities, Yunis-Varon syndromeEuropean journal of medical genetics
Enhanced proteasome activity in perifascicular myofibres is a hallmark of dermatomyositis and its inhibition is efficient in preclinical models.Debrut L, Giannini M, Quiring G, Perniola S, Rovito D, Keime C, Lannes B, Nadaj-Pakleza A, Chanson JB, Charles AL, Geny B, Metzger D, Laverny G, Meyer A2025-10-06Dermatomyositis, DM, IFN, Inclusion body myositis, IBM, KZR, PSMB8, Polymyositis, PM, antisynthetase syndrome, ASyS, experimental myositis, immune-mediated necrotising myopathy, IMNM, immunoproteasome, inflammatory myopathies, IIM, interferon, ixazomib, necrotising autoimmune myopathy, overlap myositis, proteasome, scleromyositisAnnals of the rheumatic diseases
The FAIR journey of a patient-driven registry: Reflections and practical solutions from the Duchenne Data Platform FAIRification experience.Lalout N, Wilkinson MD, Wandrei D, Tassoni A, Atalaia A, Prieto M, Camara A, Quemada E, Franken M, Jonker AH, Paliouras G, Siminiuc S, Carta C, Dos Santos Vieira B, Roos M, Kaliyaperumal R, Evangelista T, 't Hoen PAC, Vroom E2025-10-01Duchenne muscular dystrophy, FAIR data, FAIRification, data visiting, federated analyses, rare diseasesJournal of neuromuscular diseases
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study.Chitimus DM, Tard C, Fournier M, Bouhour F, Béhin A, Salort-Campana E, Lagrange E, Kaminsky AL, Magot A, Beltran S, Noury JB, Magy L, Solé G, Renard D, Spinazzi M, Demurger F, Cintas P, Nadaj-Pakleza A, Deibener-Kaminsky J, Bassez G, Taouagh N, Arrassi A, Lefeuvre C, Attarian S, Hamroun D, Laforêt P2025-10-01French registry, late‐onset Pompe disease, metabolic myopathy, mortality, respiratory failureEuropean journal of neurology
Ataxia and oculomotor apraxia caused by a large-scale deletion in the senataxin gene.Rusecka JM, Kierdaszuk B, Stępniak I, Rydzanicz M, Stawiński P, Gambin T, Loska D, Kacprzak MM, Kaliszewska M, Piekutowska-Abramczuk D, Kamińska AM, Pronicka E, Bartnik E, Kostera-Pruszczyk A, Płoski R, Sobczyńska-Tomaszewska A, Tońska K2025-08-20SETX, AOA2, CNV, MtDNA, Neurodegenerative disorder, R-loop, WESJournal of applied genetics
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons.McDonald CM, Guglieri M, Vučinić D, Acsadi G, Brandsema JF, Bruno C, Finanger EL, Harper A, Lobato ML, Masson R, Muelas N, Munell F, Nevo Y, Péréon Y, Phan H, Sansone VA, Scoto M, Willis T, Finkel RS, Vandenborne K, Cazzaniga S, Montrasio S, Alessi F, Bettica P, Mercuri E2025-08-19Duchenne muscular dystrophy, efficacy, long term, safetyAnnals of clinical and translational neurology
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.Jaubert P, Loret C, Stojkovic T, Attarian S, Bonello-Palot N, Bouhour F, Camdessanche JP, Cassereau J, Chanson JB, Cintas P, Creange A, Esselin F, Genestet S, Giordano S, Gitiaux C, Guillaud-Bataille M, Isapof A, Kumaran D, Labeyrie C, Laugel V, Leonard-Louis S, Lozeron P, Magy L, Mercier S, Merle P, Michaud M, Nicolas G, Ollagnon E, Pereon Y, Puma A, Poinsignon V, Roy SQ, Sole G, Tard C, Vidoni L, Lia AS, Echaniz-Laguna A2025-08-01CMT4C, Charcot–Marie–Tooth disease, SH3TC2 gene, SH3TC2 protein, Schwann cell, demyelinating polyneuropathy, myelinEuropean journal of neurology
Autophagy impairment is associated with enhanced satellite cell activation in muscle biopsies from younger late-onset Pompe disease patients.Severa G, Bastu S, Borin GU, Decrouy X, Codina A, Kefi K, Periou B, Nadaj-Pakleza A, Lannes B, Sacconi S, Maurage CA, Tard C, Jou C, Osorio AN, Taglietti V, Malfatti E2025-07-26GDSII, LAMP2, autophagy, histopathology, late-onset Pompe disease (LOPD), muscle biopsy, satellite cells, vacuolizationJournal of neuropathology and experimental neurology
Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers.Martínez Valle F, Galán Dávila L, Buades Reinés J, Gonzalez-Moreno J, Losada López I, Sevilla T, Muñoz Beamud F, Bárcena Llona JE, Romero Acebal M, Tarilonte P, Setaro F, Rejas-Gutierrez J, López-Ibáñez de Aldecoa A, Peral C2025-07-03Hereditary transthyretin amyloidosis with polyneuropathy, asymptomatic carrier, cost-of-illness, early stage, healthcare resources utilizationExpert review of pharmacoeconomics & outcomes research
Quantitative magnetic resonance imaging parameters of lumbar paraspinal muscles and their relationship to function and ageing in healthy subjects.Kokosova V, Krkoska P, Vlazna D, Dostal M, Ovesna P, Matulova K, Adamova B2025-07-01Magnetic resonance imaging (MRI), ageing, endurance, muscle strength, paraspinal musclesQuantitative imaging in medicine and surgery
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis.Ranieri F, Senerchia G, Bonan L, Casali S, Cabona C, Cantone M, De Marchi F, Diamanti L, Doretti A, Fini N, Filosto M, Fortuna A, Iovino A, Iuzzolino VV, Lanza G, Lunetta C, Maderna L, Mandrioli J, Mazzini L, Musumeci G, Nuredini A, Sorarù G, Toriello A, Ticozzi N, Todisco M, Vacchiano V, Zinno L, Silani V, Rossi S, Di Lazzaro V, Dubbioso R2025-06-25Annals of neurology
ALS global day 2025: research and clinical advances.Ticozzi N, Padovani A, Filosto M2025-06-17Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic Review.Aleksovska K, Kyriakides T, Angelini C, Argov Z, Claeys KG, de Visser M, Filosto M, Jovanovic I, Kostera-Pruszczyk A, Molnar MJ, Sacconi S, Schaefer J, Siciliano G, Vilchez JJ, Toscano A, Schoser B2025-06-01creatine kinase, global, hyperCKemia, myopathy, neuromuscular, normal, systematic reviewEuropean journal of neurology
MYL1-Related Congenital Myopathy: Clinical, Genetic and Pathological Insights.Madrigal I, Villar-Vera C, Arca G, Expósito-Escudero J, Rodríguez-Revenga L, Piolatti-Luna A, Muelas N, Vilchez R, Ciutad Celdran M, Codina A, Estévez-Arias B, Carrera-Garcia L, Ortez C, Rodriguez-Carunchio L, Sebastiani G, Azorin I, Nascimento A, Jou C, Vilchez JJ, Natera-de Benito D2025-06-01congenital muscular dystrophy, congenital myopathy, essential/alkali myosin light chain, fast‐twitch type II muscle fibres, muscle cell autophagy, myosin heavy chainNeuropathology and applied neurobiology
Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases.Segarra-Casas A, Domínguez-González C, Natera-de Benito D, Kapetanovic S, Hernández-Laín A, Estévez-Arias B, Llansó L, Ortez C, Jou C, Martí-Carrera I, López-Márquez A, Rodríguez MJ, González-Mera L, Nedkova V, Fernández-Torrón R, Rodríguez-Santiago B, Jimenez-Mallebrera C, Juntas-Morales R, López-de Munain A, Surrallés J, Nascimento A, Gallardo E, Olivé M, Gallano P, González-Quereda L2025-05-25RNA sequencing, alternative splicing, congenital myopathy, genetic diagnosis, muscular dystrophy, neuromuscular diseases, transcriptomicsAnnals of clinical and translational neurology
In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis.Giannini M, Quiring G, Oulad-Abdelghani M, Lannes B, Allenbach Y, Benveniste O, Boyer O, Pakleza AN, Geny B, Meyer A2025-05-22Annals of the rheumatic diseases
Expanding the clinical phenotype and understanding the biochemical consequences of Muscle Glycogen Synthase Deficiency (GSD0B).Llauradó A, Pinós T, Codina-Solà M, Martínez-Saez E, Restrepo-Vera JL, Salvadó M, Sanchez-Tejerina D, Sotoca J, Muñoz P, Rovira-Moreno E, Büyükdereli L, Garcia-Arumi E, Vidal-Taboada JM, Ovelleiro D, Juntas-Morales R2025-05-18Adult-onset myopathy, GYS1, Glycogen synthase, Glycogenosis type 0, Muscle glycogenosisMolecular genetics and metabolism
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial.Bensimon G, Leigh PN, Tree T, Malaspina A, Payan CA, Pham HP, Klaassen P, Shaw PJ, Al Khleifat A, Amador MDM, Attarian S, Bell SM, Beltran S, Bernard E, Camu W, Corcia P, Corvol JC, Couratier P, Danel V, Debs R, Desnuelle C, Dimitriou A, Ealing J, Esselin F, Fleury MC, Gorrie GH, Grapperon AM, Hesters A, Juntas-Morales R, Kolev I, Lautrette G, Le Forestier N, McDermott CJ, Pageot N, Salachas F, Sharma N, Soriani MH, Sreedharan J, Svahn J, Verber N, Verschueren A, Yildiz O, Suehs CM, Saker-Delye S, Muller C, Masseguin C, Hajduchova H, Kirby J, Garlanda C, Locati M, Zetterberg H, Asselain B, Al-Chalabi A2025-05-09Lancet (London, England)
Biallelic variants in the RFC4 gene cause a rapidly progressive congenital myopathy with severe hypotonia and axial weakness.Lauerova B, Dolanska A, Lassuthova P, Stanclova D, Rohlenova M, Morimoto M, Zuchner S, Xu IRL, Rebelo A, Haberlova J2025-04-17Cerebellar atrophy, Hearing loss, Morimoto-Ryu-Malicdan neuromuscular syndrome, Multisystemic disorders, Myopathy, RFC4Neuromuscular disorders : NMD
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey.Zucchi D, Marinello D, Tani C, Fulvio G, Aguilera S, Benachi A, Biller R, Blanco I, Borgards P, Boiteux MC, Brandi ML, Costafreda E, Fonseca JE, Fredi M, Iotova V, Louisse S, Nalli C, Onali M, Power B, Rousset-Jablonski C, Sturz D, Tincani A, Vieira A, Capela S, Dan D, De Backer J, de Die-Smulders C, Dufke A, Artzner EL, Limongelli G, Lorenz B, Papenthin W, Pascau MJ, Raidt J, Ray-Coquard I, Rimmer R, Röhl C, Schneider H, Yap T, Talarico R, Mosca M2025-03-10Pregnancy-related issues, Rare diseases, Unmet needsOrphanet journal of rare diseases
Hereditary transthyretin amyloidosis caused by the Val142Ile variant in Spain.de Frutos F, Herrador L, Peiró-Aventín B, Eiros R, Limeres Freire J, Zorio E, Carbayo Á, Llongueras Espi P, García-Álvarez A, Ripoll-Vera T, Macías R, Vilches S, Ruiz-Bustillo S, Arana-Achaga X, Gayán Ordás J, Piqueras-Flores J, Ruiz-Cueto M, Casasnovas C, Tirón C, Rojas-García R, Sevilla T, Fernando Rodríguez-Palomares J, González-López E, Villacorta E, García-Pavía P, González-Costello J2025-01-17ATTR hereditaria, Amiloidosis, Amyloidosis, Hereditary ATTR, Transthyretin, Transtirretina, p.Val142IleRevista espanola de cardiologia (English ed.)
Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests.Marti P, Pitarch-Castellano I, Muelas N, Azorín I, Fores L, Vilchez R, Sevilla T, Vilchez JJ2025-01-14Neurology
Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies.Muelas N, Carretero-Vilarroig L, Martí P, Azorín I, Frasquet M, Poyatos-García J, Portela S, Martínez-Vicente L, Argente-Escrig H, Sivera R, Vázquez-Costa JF, Tárrega M, Más-Estellés F, Vílchez R, Bataller L, Aller E, Diago L, Fores-Toribio L, Sevilla T, Vilchez JJ2025-01-07Distal dystrophy, Distal myopathy, Genetic diagnosis, NeuromyopathyJournal of neurology
In vivo mapping of sodium homeostasis disturbances in individual ALS patients: A brain 23Na MRI study.Grapperon AM, El Mendili MM, Maarouf A, Ranjeva JP, Guye M, Verschueren A, Attarian S, Zaaraoui W2025-01-01PloS one
Quantitative magnetic resonance imaging parameters of lumbar paraspinal muscle impairment in myotonic dystrophy type 2 and their evolution with aging.Kokosova V, Krkoska P, Vlazna D, Sladeckova M, Dostal M, Kerkovsky M, Barusova T, Ovesna P, Parmova O, Matulova K, Adamova B2025-01-01endurance, magnetic resonace imaging, muscle strengh, myotonic dystrophy type 2, paraspinal musclesFrontiers in neurology
Lumbar paraspinal muscles in patients with chronic non-specific low back pain and the effect of exercise: comparative and interventional study.Kokosova V, Vlazna D, Krkoska P, Sladeckova M, Dostal M, Matulova K, Gerstberger R, Ovesna P, Adamova B2025-01-01endurance, exercise therapy, low back pain, magnetic resonance imaging, muscle strength, paraspinal musclesFrontiers in rehabilitation sciences
Strength and endurance of the lumbar extensor muscles and their predictors: A cross-sectional study in healthy subjects.Vlazna D, Adamova B, Krkoska P, Kokosova V, Matulova K, Barusova T, Sladeckova M2024-12-28Dynamometer, Endurance, Low back pain, Muscle strength, Neuromuscular diseases, Paraspinal muscles, SpineJournal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology
Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic.Donin G, Mothejlová K, Horáková M, Vohanka S2024-12-20Direct healthcare costs, Myasthenia gravis, Treatment patternsOrphanet journal of rare diseases
Real-time measurement of radiation exposure in interventional radiologists during CT-guided intrathecal injections of nusinersen.Rosiak G, Franke J, Milczarek K, Konecki D, Frączek-Kozlovska A, Potulska-Chromik A, Kostera-Pruszczyk A, Łusakowska A2024-11-08CT-guided spinal injection, Nusinersen, Radiation exposure, Spinal muscular atrophyNeuroradiology
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.Cerro-Herreros E, Núñez-Manchón J, Naldaiz-Gastesi N, Carrascosa-Sàez M, García-Rey A, Losilla DP, González-Martínez I, Espinosa-Espinosa J, Moreno K, Poyatos-García J, Vilchez JJ, de Munain AL, Suelves M, Nogales-Gadea G, Llamusí B, Artero R2024-10-11Science advances
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA2024-10-01The Lancet. Neurology
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model.Poyatos-García J, Soblechero-Martín P, Liquori A, López-Martínez A, Maestre P, González-Romero E, Vázquez-Manrique RP, Muelas N, García-García G, Ohana J, Arechavala-Gomeza V, Vílchez JJ2024-10-01Becker muscular dystrophy, CRISPR-Cas9, Cell model, Duchenne muscular dystrophy, Dystrophin, Gene therapySkeletal muscle
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy.Doneddu PE, Gallo C, Gentile L, Cocito D, Falzone Y, Di Stefano V, Inghilleri M, Cosentino G, Matà S, Mazzeo A, Filosto M, Peci E, Sorrenti B, Brighina F, Moret F, Vegezzi E, Sperti M, Risi B, Nobile-Orazio E2024-09-05MMN, diagnosis, diagnostic criteria, guidelines, multifocal motor neuropathyEuropean journal of neurology
Assessment of lumbar paraspinal muscle morphology using mDixon Quant magnetic resonance imaging (MRI): a cross-sectional study in healthy subjects.Krkoska P, Kokosova V, Dostal M, Vlazna D, Kerkovsky M, Straka M, Gerstberger R, Matulova K, Ovesna P, Adamova B2024-08-01Magnetic resonance imaging (MRI), biomarkers, chemical shift imaging, lumbar spine, paraspinal musclesQuantitative imaging in medicine and surgery
Defining the landscape of TIA1 and SQSTM1 digenic myopathy.Panos-Basterra P, Theuriet J, Nadaj-Pakleza A, Magot A, Lannes B, Marcorelles P, Behin A, Masingue M, Caillon F, Malek Y, Fenouil T, Bas J, Menassa R, Michel-Calemard L, Streichenberger N, Simon JP, Bouhour F, Evangelista T, Métay C, Pegat A, Stojkovic T, Fernández-Eulate G2024-07-24Digenic inheritance, Distal myopathy, Myofibrillar myopathy, Rimmed vacuoles, TIA1/SQSTM1 myopathyNeuromuscular disorders : NMD
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.Huin V, Blum D, Delforge V, Cailliau E, Djeziri S, Dujardin K, Genet A, Viard R, Attarian S, Bruneteau G, Cassereau J, Genestet S, Kaminsky AL, Soriani MH, Lefilliatre M, Couratier P, Pittion-Vouyovitch S, Esselin F, De La Cruz E, Guy N, Kolev I, Corcia P, Cintas P, Desnuelle C, Buée L, Danel-Brunaud V, Devos D, Rolland AS2024-07-11Amyotrophic lateral sclerosis, Caffeine, Cognition, Nutrition, Single nucleotide polymorphismNeurobiology of disease
Safety, efficacy and steroid-sparing effect of amifampridine in Lambert-Eaton myasthenic syndrome patients - real world data.Szczudlik P, Sobieszczuk E, Walczak M, Kostera-Pruszczyk A2024-06-27LEMS, Lambert-Eaton myasthenic syndrome, amifampridine, efficacy, safety, treatmentNeurologia i neurochirurgia polska
Compound heterozygous variants in MYBPC1 lead to severe distal arthrogryposis type-1 manifestations.Iyer A, Lauerova B, Mariano J, Haberlová J, Lassuthova P, Zidkova J, Wright NT, Kontrogianni-Konstantopoulos A2024-06-05Autosomal recessive inheritance, Distal arthrogryposis type-1, MYBPC1Gene
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis.Alarcan H, Bruno C, Emond P, Raoul C, Vourc'h P, Corcia P, Camu W, Veyrune JL, Garlanda C, Locati M, Juntas-Morales R, Saker S, Suehs C, Masseguin C, Kirby J, Shaw P, Malaspina A, De Vos J, Al-Chalabi A, Leigh PN, Tree T, Bensimon G, Blasco H2024-05-21amyotrophic lateral sclerosis, interleukin‐2, kynurenine pathway, metabolomics, pharmacometabolomicsAnnals of the New York Academy of Sciences
Effect of exercise-based cancer rehabilitation via telehealth: a systematic review and meta-analysis.Batalik L, Chamradova K, Winnige P, Dosbaba F, Batalikova K, Vlazna D, Janikova A, Pepera G, Abu-Odah H, Su JJ2024-05-17Cancer rehabilitation, Exercise-based rehabilitation, Home-based exercise, TelehealthBMC cancer
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam.Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Scalco RS, Fontoura P, Muntoni F2024-05-11Motor function, Risdiplam, SMA, Safety, Spinal muscular atrophyJournal of neurology
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021.Schirinzi E, Bochicchio MA, Lochmüller H, Vissing J, Jordie-Diaz-Manerae, Evangelista T, Plançon JP, Fanucci L, Marini M, Tonacci A, Mancuso M, Segovia-Kueny S, Toscano A, Angelini C, Schoser B, Sacconi S, Siciliano G2024-05-08e-Health, neuromuscular diseases, remote monitoring, telemedicineJournal of neuromuscular diseases
Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis.Theuriet J, Masingue M, Behin A, Ferreiro A, Bassez G, Jaubert P, Tarabay O, Fer F, Pegat A, Bouhour F, Svahn J, Petiot P, Jomir L, Chauplannaz G, Cornut-Chauvinc C, Manel V, Salort-Campana E, Attarian S, Fortanier E, Verschueren A, Kouton L, Camdessanché JP, Tard C, Magot A, Péréon Y, Noury JB, Minot-Myhie MC, Perie M, Taithe F, Farhat Y, Millet AL, Cintas P, Solé G, Spinazzi M, Esselin F, Renard D, Sacconi S, Ezaru A, Malfatti E, Mallaret M, Magy L, Diab E, Merle P, Michaud M, Fournier M, Pakleza AN, Chanson JB, Lefeuvre C, Laforet P, Richard P, Sternberg D, Villar-Quiles RN, Stojkovic T, Eymard B2024-05-02CMS, genetic, myasthenia, neuromuscular junctionBrain : a journal of neurology
Bridging the Gap: Translational Medicine and Novel Therapies in Neuromuscular Diseases.Filosto M2024-04-30Journal of integrative neuroscience
Could the motor unit number index be an early prognostic biomarker for amyotrophic lateral sclerosis?Grapperon AM, Harlay V, Boucekine M, Devos D, Rolland AS, Desnuelle C, Delmont E, Verschueren A, Attarian S2024-04-26Amyotrophic lateral sclerosis, Biomarker, Lower motor neuron, Motor unit number index, PrognosisClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis.Esteller D, Schiava M, Verdú-Díaz J, Villar-Quiles RN, Dibowski B, Venturelli N, Laforet P, Alonso-Pérez J, Olive M, Domínguez-González C, Paradas C, Vélez B, Kostera-Pruszczyk A, Kierdaszuk B, Rodolico C, Claeys K, Pál E, Malfatti E, Souvannanorath S, Alonso-Jiménez A, de Ridder W, De Smet E, Papadimas G, Papadopoulos C, Xirou S, Luo S, Muelas N, Vilchez JJ, Ramos-Fransi A, Monforte M, Tasca G, Udd B, Palmio J, Sri S, Krause S, Schoser B, Fernández-Torrón R, López de Munain A, Pegoraro E, Farrugia ME, Vorgerd M, Manousakis G, Chanson JB, Nadaj-Pakleza A, Cetin H, Badrising U, Warman-Chardon J, Bevilacqua J, Earle N, Campero M, Díaz J, Ikenaga C, Lloyd TE, Nishino I, Nishimori Y, Saito Y, Oya Y, Takahashi Y, Nishikawa A, Sasaki R, Marini-Bettolo C, Guglieri M, Straub V, Stojkovic T, Carlier RY, Díaz-Manera J2024-04-01Journal of neurology
Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy.Sanso MAR, Rodriguez AR, Vicente LM, Sevilla T, Garro CB, Martín JF, Vicente AA, de la Prida MM, Dávila LG, Vázquez LG, Valle FM, Pons CC, Bau AF, Barroso EC, López IL, González-Moreno J2024-03-30ATTR, Amiloidosis por transtirretina, Polineuropatía, Polyneuropathy, Real-life, Tafamidis, Transthyretin amyloidosis, Vida realMedicina clinica
Hereditary motor sensory neuropathy with proximal involvement (HMSN-P) associated with TFG p.Pro285Leu variant in an Italian family with a motor neuron disease-like clinical picture.Cabras S, Di Pede F, Canosa A, Grassano M, Mongini TE, Gadaleta G, Calvo A, Chiò A, Moglia C, Gallone S2024-03-27Muscle & nerve
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA.Germani S, Van Ho AT, Cherubini A, Varone E, Chernorudskiy A, Renna GM, Fumagalli S, Gobbi M, Lucchetti J, Bolis M, Guarrera L, Craparotta I, Rastelli G, Piccoli G, de Napoli C, Nogara L, Poggio E, Brini M, Cattaneo A, Bachi A, Simmen T, Calì T, Quijano-Roy S, Boncompagni S, Blaauw B, Ferreiro A, Zito E2024-03-19ER stress, ERO1, SEPN1, TUDCA, core myopathy, multi mini-core diseaseCell reports. Medicine
Myasthenia gravis concurrent with Parkinson's disease in a Spanish cohort. Causation or correlation?Gamez J, Carmona F, Lorenzo-Bosquet C, Cuberas-Borrós G, de Fabregues O, Gamez A2024-02-01Comorbidity, DaT Scan, Epidemiology, Head drop, Late-onset myasthenia gravis, Parkinson’s diseaseNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Criterion validity of the spatial exploration test of upper limb mobility to evaluate the active horizontal workspace of children with spinal muscular atrophy.Pruvost S, Gomez Garcia de la Banda M, Quijano Roy S, Izedaren F, Roche N, Pouplin S2024-02-01Spinal muscular atrophy, children, functional assessment, spatial exploration, upper limbDisability and rehabilitation
Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum.Carbayo Á, Borrego-Écija S, Turon-Sans J, Cortés-Vicente E, Molina-Porcel L, Gascón-Bayarri J, Rubio MÁ, Povedano M, Gámez J, Sotoca J, Juntas-Morales R, Almendrote M, Marquié M, Sánchez-Valle R, Illán-Gala I, Dols-Icardo O, Rubio-Guerra S, Bernal S, Caballero-Ávila M, Vesperinas A, Gelpi E, Rojas-García R2024-01-16amyotrophic lateral sclerosis, frontotemporal dementia, motor neuron disease, neuropathologyBrain : a journal of neurology
Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.Esteller D, Schiava M, Verdú-Díaz J, Villar-Quiles RN, Dibowski B, Venturelli N, Laforet P, Alonso-Pérez J, Olive M, Domínguez-González C, Paradas C, Vélez B, Kostera-Pruszczyk A, Kierdaszuk B, Rodolico C, Claeys K, Pál E, Malfatti E, Souvannanorath S, Alonso-Jiménez A, de Ridder W, De Smet E, Papadimas G, Papadopoulos C, Xirou S, Luo S, Muelas N, Vilchez JJ, Ramos-Fransi A, Monforte M, Tasca G, Udd B, Palmio J, Sri S, Krause S, Schoser B, Fernández-Torrón R, López de Munain A, Pegoraro E, Farrugia ME, Vorgerd M, Manousakis G, Chanson JB, Nadaj-Pakleza A, Cetin H, Badrising U, Warman-Chardon J, Bevilacqua J, Earle N, Campero M, Díaz J, Ikenaga C, Lloyd TE, Nishino I, Nishimori Y, Saito Y, Oya Y, Takahashi Y, Nishikawa A, Sasaki R, Marini-Bettolo C, Guglieri M, Straub V, Stojkovic T, Carlier RY, Díaz-Manera J2023-12-01Multisystemic proteinopathy, Muscle MRI, VCP myopathy, ValosinJournal of neurology
Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study.Chanson JB, Bouhour F, Aubé-Nathier AC, Mallaret M, Vial C, Hacquard A, Petiot P, Spinazzi M, Nadaj-Pakleza A, Echaniz-Laguna A2023-12-01Frail elderly, Iatrogenic diseases, Myasthenia gravis, PrognosisJournal of neurology
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scalco RS, Wagner KR, Muntoni F2023-10-01Neurology and therapy
Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience.Łusakowska A, Wójcik A, Frączek A, Aragon-Gawińska K, Potulska-Chromik A, Baranowski P, Nowak R, Rosiak G, Milczarek K, Konecki D, Gierlak-Wójcicka Z, Burlewicz M, Kostera-Pruszczyk A2023-08-04Computed tomography–guided lumbar puncture, Functional tests, Nusinersen, Patient global impression – improvement, SMN2 gene, Scoliosis, Spinal muscular atrophyOrphanet journal of rare diseases
Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.Asensi Cantó P, Mayordomo E, Dorado A, Villalba M, Mañez RB, González E, Salavert M, Facal A, Chorão P, Balaguer A, Sivera R, Montoro J, Vilchez JJ, Piñana JL, Sanz M, Sanz J, Muelas N, Guerreiro M2023-08-01encephalitis, myositis, stem cell transplant, toxoplasmosisTransplant infectious disease : an official journal of the Transplantation Society
Translation, reliability, and validity of the Norwegian version of the ABILHAND-NMD and the ACTIVLIM for Myotonic Dystrophy type 1.Fossmo HL, Ørstavik K, Frich JC, Robinson HS2023-07-12Muscle disease, PROM, neuromuscular disorder, patient reported outcome measures, psychometric propertiesDisability and rehabilitation
253rd ENMC international workshop: Striated muscle laminopathies - natural history and clinical trial readiness. 24-26 June 2022, Hoofddorp, the Netherlands.Maggi L, Quijano-Roy S, Bönnemann C, Bonne G2023-06-01Emery-Dreifuss, Heart, LMNA, Lamins, MyopathyNeuromuscular disorders : NMD
Limb-girdle myopathy and mild intellectual disability: The expanding spectrum of TANGO2-related disease.Restrepo-Vera JL, Muñoz-Cabello P, Pérez-Rodon J, Rovira-Moreno E, Codina-Solà M, Llauradó A, Salvadó M, Sánchez-Tejerina D, Sotoca J, Martínez-Sáez E, García-Arumí E, Juntas-Morales R2023-06-01ER-to-Golgi traffic, Intellectual disability, Limb-girdle, Mitochondria, Myopathy, TANGO2Neuromuscular disorders : NMD
Distal hereditary motor neuropathy due to a novel YARS1 gene pathogenic variant.Llauradó A, Gratacòs-Viñola M, Rovira-Moreno E, Codina-Solà M, Salvadó M, Sanchez-Tejerina D, Sotoca J, Raguer N, Garcia-Arumi E, Juntas-Morales R2023-06-01Muscle & nerve
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain.de Frutos F, Ochoa JP, Gómez-González C, Reyes-Leiva D, Aróstegui JI, Casasnovas C, Barriales-Villa R, Sevilla T, Gonzalez-Lopez E, Ramil E, Galan L, González-Costello J, García-Álvarez A, Rojas-Garcia R, Espinosa MA, Garcia-Pavia P2023-06-01Amyloidosis, Glu89Lys, founder effect, hereditary ATTR, transthyretinAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.Sanchez-Tejerina D, Llaurado A, Sotoca J, Lopez-Diego V, Vidal Taboada JM, Salvado M, Juntas-Morales R2023-04-18amyotrophic lateral sclerosis (ALS), biomarker, genetics, neurofilament light (NfL) protein, neuroinflammation, pharmacodynamic biomarker, prognosisCells
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scalco RS, Wagner KR, Muntoni F2023-04-01Evrysdi, Pharmacodynamics, Risdiplam, Safety, Spinal muscular atrophyNeurology and therapy
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies.Vulsteke JB, Derua R, Dubucquoi S, Coutant F, Sanges S, Goncalves D, Wuyts G, De Haes P, Blockmans D, Wuyts WA, Claeys KG, De Langhe E, Fabien N, Bossuyt X2023-04-01Autoantibodies, Autoimmune Diseases, Autoimmunity, PolymyositisAnnals of the rheumatic diseases
Follow-up regimens for carriers of hereditary transthyretin variants.Losada-López IA, Kapetanovic-García S, Sevilla-Mantecón T, Muñoz-Beamud F2023-03-10Medicina clinica
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinineratio, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.van de Velde NM, Koeks Z, Signorelli M, Verwey N, Overzier M, Bakker JA, Sajeev G, Signorovitch J, Ricotti V, Verschuuren J, Brown K, Spitali P, Niks EH2023-02-28Neurology
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.Bril V, Szczudlik A, Vaitkus A, Rozsa C, Kostera-Pruszczyk A, Hon P, Bednarik J, Tyblova M, Köhler W, Toomsoo T, Nowak RJ, Mozaffar T, Freimer ML, Nicolle MW, Magnus T, Pulley MT, Rivner M, Dimachkie MM, Distad BJ, Pascuzzi RM, Babiar D, Lin J, Querolt Coll M, Griffin R, Mondou E2023-02-14Neurology
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis.Vulsteke JB, Smith V, Bonroy C, Derua R, Blockmans D, De Haes P, Vanderschueren S, Lenaerts JL, Claeys KG, Wuyts WA, Verschueren P, Vanhandsaeme G, Piette Y, De Langhe E, Bossuyt X2023-02-01Autoantibodies, Mass spectrometry, Systemic sclerosis, Telomerase, TelomereJournal of autoimmunity
Adherence and Effect of Home-Based Rehabilitation with Telemonitoring Support in Patients with Chronic Non-Specific Low Back Pain: A Pilot Study.Krkoska P, Vlazna D, Sladeckova M, Minarikova J, Barusova T, Batalik L, Dosbaba F, Vohanka S, Adamova B2023-01-13adherence, disability, home-based rehabilitation, low back pain, muscle strength, muscular endurance, pain, paraspinal muscles, telemonitoringInternational journal of environmental research and public health
Trunk muscle dysfunction in patients with myotonic dystrophy type 2 and its contribution to chronic low back pain.Vlazna D, Krkoska P, Sladeckova M, Parmova O, Barusova T, Hrabcova K, Vohanka S, Matulova K, Adamova B2023-01-01function tests, low back pain, muscle strength, muscular endurance, myotonic dystrophy type 2 (MD2), neuromuscular diseases (NMD), paraspinal muscles, respiratory musclesFrontiers in neurology
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.Ayyar Gupta V, Pitchforth JM, Domingos J, Ridout D, Iodice M, Rye C, Chesshyre M, Wolfe A, Selby V, Mayhew A, Mazzone ES, Ricotti V, Hogrel JY, Niks EH, de Groot I, Servais L, Straub V, Mercuri E, Manzur AY, Muntoni F2023-01-01PloS one
Case report: radiation-induced lumbosacral plexopathy - a very late complication of radiotherapy for cervical cancer.Krkoska P, Kazda T, Vlazna D, Adamova B2022-12-12Case report, Cervical cancer, Lumbosacral plexus, Radiation-induced lumbosacral plexopathy, RadiotherapyBMC neurology
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.Baviera-Muñoz R, Carretero-Vilarroig L, Vázquez-Costa JF, Morata-Martínez C, Campins-Romeu M, Muelas N, Sastre-Bataller I, Martínez-Torres I, Pérez-García J, Sivera R, Sevilla T, Vilchez JJ, Jaijo T, Espinós C, Millán JM, Bataller L, Aller E2022-12-01Neurology. Genetics
European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders.van den Bersselaar LR, Heytens L, Silva HCA, Reimann J, Tasca G, Díaz-Cambronero Ó, Løkken N, Hellblom A, Hopkins PM, Rueffert H, Bastian B, Vilchez JJ, Gillies R, Johannsen S, Veyckemans F, Muenster T, Klein A, Litman R, Jungbluth H, Riazi S, Voermans NC, Snoeck MMJ2022-12-01anaesthesia, malignant hyperthermia, myopathy, neuromuscular disorders, perioperative careEuropean journal of neurology
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update.Brannagan TH, Coelho T, Wang AK, Polydefkis MJ, Dyck PJ, Berk JL, Drachman B, Gorevic P, Whelan C, Conceição I, Plante-Bordeneuve V, Merlini G, Obici L, Plana JMC, Gamez J, Kristen AV, Mazzeo A, Gentile L, Narayana A, Olugemo K, Aquino P, Benson MD, Gertz M2022-12-01Clinical trial, Familial amyloid polyneuropathy, Hereditary transthyretin amyloidosis, Inotersen, Peripheral neuropathies, PolyneuropathyJournal of neurology
Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain.Raputova J, Rajdova A, Vollert J, Srotova I, Rebhorn C, Üçeyler N, Birklein F, Sommer C, Vlckova E, Bednarik J2022-11-01European journal of pain (London, England)
Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45-55 Deletion.Poyatos-García J, Martí P, Liquori A, Muelas N, Pitarch I, Martinez-Dolz L, Rodríguez B, Gonzalez-Quereda L, Damiá M, Aller E, Selva-Gimenez M, Vilchez R, Diaz-Manera J, Alonso-Pérez J, Barcena JE, Jauregui A, Gámez J, Aladrén JA, Fernández A, Montolio M, Azorin I, Hervas D, Casasús A, Nieto M, Gallano P, Sevilla T, Vilchez JJ2022-11-01Annals of neurology
An Atypical Presentation of Upper Motor Neuron Predominant Juvenile Amyotrophic Lateral Sclerosis Associated with TARDBP Gene: A Case Report and Review of the Literature.Sánchez-Tejerina D, Restrepo-Vera JL, Rovira-Moreno E, Codina-Sola M, Llauradó A, Sotoca J, Salvado M, Raguer N, García-Arumí E, Juntas-Morales R2022-08-19TARDBP, TDP-43, juvenile amyotrophic lateral sclerosis, upper motor neuron predominant disorderGenes
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.Sherlock SP, Palmer J, Wagner KR, Abdel-Hamid HZ, Bertini E, Tian C, Mah JK, Kostera-Pruszczyk A, Muntoni F, Guglieri M, Brandsema JF, Mercuri E, Butterfield RJ, McDonald CM, Charnas L, Marraffino S2022-08-01Biomarkers, Domagrozumab, Duchenne muscular dystrophy, Imaging, MRI, Neuromuscular diseaseJournal of neurology
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.Statland JM, Campbell C, Desai U, Karam C, Díaz-Manera J, Guptill JT, Korngut L, Genge A, Tawil RN, Elman L, Joyce NC, Wagner KR, Manousakis G, Amato AA, Butterfield RJ, Shieh PB, Wicklund M, Gamez J, Bodkin C, Pestronk A, Weihl CC, Vilchez-Padilla JJ, Johnson NE, Mathews KD, Miller B, Leneus A, Fowler M, van de Rijn M, Attie KM2022-07-01FSHD, controlled trial, facioscapulohumeral muscular dystrophy, randomizedMuscle & nerve
Clinical and genetic spectrum of a large cohort of patients with δ-sarcoglycan muscular dystrophy.Alonso-Pérez J, González-Quereda L, Bruno C, Panicucci C, Alavi A, Nafissi S, Nilipour Y, Zanoteli E, Isihi LMA, Melegh B, Hadzsiev K, Muelas N, Vílchez JJ, Dourado ME, Kadem N, Kutluk G, Umair M, Younus M, Pegorano E, Bello L, Crawford TO, Suárez-Calvet X, Töpf A, Guglieri M, Marini-Bettolo C, Gallano P, Straub V, Díaz-Manera J2022-04-18LGMD-R6/2F, SGCD, delta-sarcoglycan, muscular dystrophies, registriesBrain : a journal of neurology
Myasthenia gravis-treatment and severity in nationwide cohort.Sobieszczuk E, Napiórkowski Ł, Szczudlik P, Kostera-Pruszczyk A2022-04-01Myasthenia gravis, hospitalization, immunoglobulins, immunosuppression, mortalityActa neurologica Scandinavica
The Splicing of the Mitochondrial Calcium Uniporter Genuine Activator MICU1 Is Driven by RBFOX2 Splicing Factor during Myogenic Differentiation.Vecellio Reane D, Cerqua C, Sacconi S, Salviati L, Trevisson E, Raffaello A2022-02-24alternative splicing, mitochondrial calcium homeostasis, myogenic differentiation, skeletal muscleInternational journal of molecular sciences
Optimized Flow Cytometry Strategy for Phenotyping Intramuscular Leukocytes: Application to the Evaluation of Myopathological Processes.Saidj T, Baba Amer Y, Plonquet A, Henry A, Souvannanorath S, Relaix F, Beldi-Ferchiou A, Authier FJ2022-02-24Flow cytometry, Inflammatory myopathy, Lymphocytes, Muscular dystrophy, Myofiber necrosis, MyopathyJournal of neuropathology and experimental neurology
Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study.Kec D, Rajdova A, Raputova J, Adamova B, Srotova I, Nekvapilova EK, Michalcakova RN, Horakova M, Belobradkova J, Olsovsky J, Weber P, Hajas G, Kaiserova M, Mazanec R, Potockova V, Ehler E, Forgac M, Birklein F, Üçeyler N, Sommer C, Bednarik J, Vlckova E2022-02-01European journal of pain (London, England)
Functional Ability and Physical Activity in Hereditary Neuromuscular Diseases.Andries A, Van Walsem MR, Ørstavik K, Frich JC2022-01-01Neuromuscular diseases, charcot-marie-tooth disease, exercise, muscular dystrophies, physical functional performanceJournal of neuromuscular diseases
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.Jakubikova M, Tyblova M, Tesar A, Magda H, Daniela V, Irena R, Iveta N, Kristyna D, Pavel D, Jiri P, Stanislav V, Josef B2022-01-01European journal of neurology
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.Cerro-Herreros E, González-Martínez I, Moreno N, Espinosa-Espinosa J, Fernández-Costa JM, Colom-Rodrigo A, Overby SJ, Seoane-Miraz D, Poyatos-García J, Vilchez JJ, López de Munain A, Varela MA, Wood MJ, Pérez-Alonso M, Llamusí B, Artero R2021-12-03CTG repeat expansions, MBNL1 protein, alternative splicing, antisense oligonucleotide, microRNAs, myotonic dystrophy, therapeutic gene modulation, tissue distribution, transcriptomicsMolecular therapy. Nucleic acids
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B2021-12-01The Lancet. Neurology
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases.Pisella LI, Fernandes S, Solé G, Stojkovic T, Tard C, Chanson JB, Bouhour F, Salort-Campana E, Beaudonnet G, Debergé L, Duval F, Grapperon AM, Masingue M, Nadaj-Pakleza A, Péréon Y, Audic F, Behin A, Friedman D, Magot A, Noury JB, Souvannanorath S, Wahbi K, Antoine JC, Bigaut K, Camdessanché JP, Cintas P, Debs R, Espil-Taris C, Kremer L, Kuntzer T, Laforêt P, Laugel V, Mallaret M, Michaud M, Nollet S, Svahn J, Vicart S, Villar-Quiles RN, Desguerre I, Adams D, Segovia-Kueny S, Merret G, Hammouda E, Molon A, Attarian S2021-10-26COVID-19, Neuromuscular diseases, Prognosis, Risk factorOrphanet journal of rare diseases
Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study.Grapperon AM, Verschueren A, Jouve E, Morizot-Koutlidis R, Lenglet T, Pradat PF, Salachas F, Bernard E, Delstanche S, Maertens de Noordhout A, Guy N, Danel V, Delval A, Delmont E, Rolland AS, Pulse Study Group, Jomir L, Devos D, Wang F, Attarian S2021-10-01Amyotrophic lateral sclerosis, Transcranial magnetic stimulation, Triple stimulation technique, Upper motor neuronClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.Jakubíková M, Týblová M, Tesař A, Horáková M, Vlažná D, Ryšánková I, Nováková I, Dolečková K, Dušek P, Piťha J, Voháňka S, Bednařík J2021-10-01COVID-19, corticosteroids, immunosuppression, myasthenia gravis, rituximabEuropean journal of neurology
A recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.Biancalana V, Rendu J, Chaussenot A, Mecili H, Bieth E, Fradin M, Mercier S, Michaud M, Nougues MC, Pasquier L, Sacconi S, Romero NB, Marcorelles P, Authier FJ, Gelot Bernabe A, Uro-Coste E, Cances C, Isidor B, Magot A, Minot-Myhie MC, Péréon Y, Perrier-Boeswillwald J, Bretaudeau G, Dondaine N, Bouzenard A, Pizzimenti M, Eymard B, Ferreiro A, Laporte J, Fauré J, Böhm J2021-09-17Calcium, Congenital myopathy, Excitation–contraction coupling, Muscle weakness, Neuromuscular disorder, TriadActa neuropathologica communications
Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in Spanish league soccer players.Gamez J, Carmona F2021-09-15Amyotrophic lateral sclerosis, Early onset, Physical exercise, Risk factor, Soccer, TraumaJournal of the neurological sciences
International retrospective natural history study of LMNA-related congenital muscular dystrophy.Ben Yaou R, Yun P, Dabaj I, Norato G, Donkervoort S, Xiong H, Nascimento A, Maggi L, Sarkozy A, Monges S, Bertoli M, Komaki H, Mayer M, Mercuri E, Zanoteli E, Castiglioni C, Marini-Bettolo C, D'Amico A, Deconinck N, Desguerre I, Erazo-Torricelli R, Gurgel-Giannetti J, Ishiyama A, Kleinsteuber KS, Lagrue E, Laugel V, Mercier S, Messina S, Politano L, Ryan MM, Sabouraud P, Schara U, Siciliano G, Vercelli L, Voit T, Yoon G, Alvarez R, Muntoni F, Pierson TM, Gómez-Andrés D, Reghan Foley A, Quijano-Roy S, Bönnemann CG, Bonne G2021-07-01LMNA, early onset, laminopathies, muscular dystrophy, striated muscleBrain communications
Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants.Borrego-Écija S, Turon-Sans J, Ximelis T, Aldecoa I, Molina-Porcel L, Povedano M, Rubio MA, Gámez J, Cano A, Paré-Curell M, Bajo L, Sotoca J, Clarimón J, Balasa M, Antonell A, Lladó A, Sánchez-Valle R, Rojas-García R, Gelpi E2021-05-01ALS-FTD, Alzheimer’s disease, TDP-43 protein, amyotrophic lateral sclerosis, frontotemporal dementia, neuropathologyBrain pathology (Zurich, Switzerland)
A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging.Muelas N, Frasquet M, Más-Estellés F, Martí P, Martínez-Vicente L, Sevilla T, Azorín I, Poyatos-García J, Argente-Escrig H, Vílchez R, Vázquez-Costa JF, Bataller L, Vilchez JJ2021-04-01MYH7, distal myopathy, heatmap, laing distal myopathy, muscle MRIEuropean journal of neurology
Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndrome.Argente-Escrig H, Schultheis D, Kamm L, Schowalter M, Thiel C, Türk M, Clemen CS, Muelas N, Castañón MJ, Wiche G, Herrmann H, Vilchez JJ, Schröder R2021-02-01Neuropathology and applied neurobiology
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, Gilhus NE, Illa I, Kuntz NL, Massey J, Melms A, Murai H, Nicolle M, Palace J, Richman D, Verschuuren J2021-01-19Neurology
Spinal muscular atrophy: epidemiology and health burden in children - a Polish national healthcare database perspective before introduction of SMA-specific treatment.Kostera-Pruszczyk A, Napiórkowski Ł, Szymańska K, Jędrzejczak J, Roszkowski M, Słowiński J, Frączek A, Ryglewicz D, Więckowska B2021-01-01epidemiology, healthcare burden, incidence, spinal muscular atrophyNeurologia i neurochirurgia polska
Long-term survival analysis of masitinib in amyotrophic lateral sclerosis.Mora JS, Bradley WG, Chaverri D, Hernández-Barral M, Mascias J, Gamez J, Gargiulo-Monachelli GM, Moussy A, Mansfield CD, Hermine O, Ludolph AC2021-01-01clinical trials, masitinib, therapy, tyrosine kinase inhibitorTherapeutic advances in neurological disorders
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019.Pini J, Siciliano G, Lahaut P, Braun S, Segovia-Kueny S, Kole A, Hérnando I, Selb J, Schirinzi E, Duong T, Hogrel JY, Olmedo JJS, Vissing J, Servais L, Vincent-Genod D, Vuillerot C, Bannwarth S, Eggenspieler D, Vicart S, Diaz-Manera J, Lochmüller H, Sacconi S2021-01-01e-Health, eNMD congress, innovation, neuromuscular disease, unmet needsJournal of neuromuscular diseases
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3.Maggi L, Bello L, Bonanno S, Govoni A, Caponnetto C, Passamano L, Grandis M, Trojsi F, Cerri F, Ferraro M, Bozzoni V, Caumo L, Piras R, Tanel R, Saccani E, Meneri M, Vacchiano V, Ricci G, Soraru' G, D'Errico E, Tramacere I, Bortolani S, Pavesi G, Zanin R, Silvestrini M, Politano L, Schenone A, Previtali SC, Berardinelli A, Turri M, Verriello L, Coccia M, Mantegazza R, Liguori R, Filosto M, Marrosu G, Siciliano G, Simone IL, Mongini T, Comi G, Pegoraro E2020-11-01Journal of neurology, neurosurgery, and psychiatry
Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum.Panadés-de Oliveira L, Bermejo-Guerrero L, de Fuenmayor-Fernández de la Hoz CP, Cantero Montenegro D, Hernández Lain A, Martí P, Muelas N, Vilchez JJ, Domínguez-González C2020-09-01ANO5 gene, Asymptomatic hyperCKemia, Calf hypertrophy, Exercise intolerance, Inflammatory biopsy, STIR sequencesJournal of neurology
HNRNPDL-related limb girdle muscular dystrophy in a Spanish family with scapulo-peroneal phenotype, the first family in Europe.Vicente LM, Martí P, Azorín I, Olivé M, Muelas N, Vilchez JJ2020-07-15HNRNPDL, IBM, Inclusion body myopathies, LGMD D3, Limb girdle muscle dystrophy, MyopathyJournal of the neurological sciences
Anti-Müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies.Parmova O, Vlckova E, Hulova M, Mensova L, Crha I, Stradalova P, Kralickova E, Jurikova L, Podborska M, Mazanec R, Dusek L, Jarkovsky J, Bednarik J, Vohanka S, Srotova I2020-06-05Medicine
The Association of methylprednisolone dosing to cessation of myotonia in a patient with myotonic dystrophy type 1.Horáková M, Horák T, Bednařík J, Voháňka S2020-05-01Corticosteroids, Methylprednisolone, Muscle relaxation, Myotonia, Myotonic dystrophy, TherapyNeuromuscular disorders : NMD
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study.Gamez J, Salvadó M, Reig N, Suñé P, Casasnovas C, Rojas-Garcia R, Insa R2019-06-01Amyloidogenesis inhibitor, TTR aggregation, TTR stabilization, catechol O-methyltransferase inhibitors, drug repositioning, drug repurposing, hereditary ATTR amyloidosis, proof-of-concept, tolcapone, transthyretinAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Haplotype Analysis of the First A4V-SOD1 Spanish Family: Two Separate Founders or a Single Common Founder?Garcia C, Vidal-Taboada JM, Syriani E, Salvado M, Morales M, Gamez J2019-01-01A4V, ALS1, SOD1, amyotrophic lateral sclerosis, familial amyotrophic lateral sclerosis, founder effect, p.A5VFrontiers in genetics
Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis.Gamez J, Salvadó M, Carmona F, de Nadal M, Romero L, Ruiz D, Jáuregui A, Martínez O, Pérez J, Suñé P, Deu M2019-01-01clinical trial, immunoglobulin, myasthenia, myasthenic crisis, thymectomyTherapeutic advances in neurological disorders
Intravenous immunoglobulin as monotherapy for myasthenia gravis during pregnancy.Gamez J, Salvado M, Casellas M, Manrique S, Castillo F2017-12-15Delivery, IVIg, Monotherapy, Myasthenia gravis, Pregnancy, Transient neonatal myasthenia, TreatmentJournal of the neurological sciences
TitleAuthorsDateKeywordsIssue name
Last update: November 7th, 2026 on 02:30